Does MBL2 codon 54 polymorphism play a role in the pathogenesis of psoriasis?

International Journal of Dermatology

Volumn 53, Issue 1, 2014, Pages 34-38

  Turan, Hakan ^a   Karkucak, Mutlu ^b   Yakut, Tahsin ^b   Ozsahin, Mustafa ^a   Gurlevik, Zehra ^a   Yanik, Mehmet Emin ^a   Ucgun, Taner ^a   Aliagaoglu, Cihangir ^a   Yaykasli, Kursat Oguz ^a  

^a DUZCE UNIVERSITY   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; CYTOKINE RELEASE; DNA POLYMORPHISM; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MALE; MANNOSE BINDING LECTIN 2 GENE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN BLOOD LEVEL; PSORIASIS VULGARIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

ADULT; CODON; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; TURKEY; YOUNG ADULT;

EID: 84890708348     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2012.5657.x     Document Type: Article

References (30)

1. Reich K, Westphal G, Schulz T, et al. Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 1999; 113: 214-220.
2. Bos JD, De Rie MA. The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 1999; 20: 40-46.
3. Terai I, Kobayashi K, Matsushita M, et al. Relationship between gene polymorphisms of mannose-binding lectin (MBL) and two molecular forms of MBL. Eur J Immunol 2003; 33: 2755-2763.
4. Dumestre-Perard C, Ponard D, Arlaud GJ, et al. Evaluation and clinical interest of mannan-binding lectin function in human plasma. Mol Immunol 2002; 39: 465-473.
5. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol Immunol 2003; 40: 73-84.
6. Madsen HO, Garred P, Thiel S, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155: 3013-3020.
7. Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 2001; 180: 86-99.
8. Vardar F, Pehlivan S, Onay H, et al. Association between mannose-binding lectin polymorphisms and predisposition to bacterial meningitis. Turk J Pediatr 2007; 49: 270-273.
9. Duffin KC, Chandran V, Gladman DD, et al. Genetics of psoriasis and psoriatic arthritis: update and future direction. J Rheumatol 2008; 35: 1449-1453.
10. Ritchlin C, Haas-Smith SA, Hicks D, et al. Patterns of cytokine production in psoriatic synovium. J Rheumatol 1998; 25: 1544-1552.
11. Abanmi A, Al Harthi F, Al Agla R, et al. Serum levels of proinflammatory cytokines in psoriasis patients from Saudi Arabia. Int J Dermatol 2005; 44: 82-83.
12. Mussi A, Bonifati C, Carducci M, et al. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. J Biol Regul Homeost Agents 1997; 11: 115-158.
13. Chodorowska G. Plasma concentrations of IFN-gamma and TNF-alpha in psoriatic patients before and after local treatment with dithranol ointment. J Eur Acad Dermatol Venereol 1998; 10: 147-151.
14. Mizutani H, Ohmoto Y, Mizutani T, et al. Role of increased production of monocytes TNF-alpha, IL-1beta and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatments. J Dermatol Sci 1997; 14: 145-153.
15. Okubo Y, Koga M. Peripheral blood monocytes in psoriatic patients overproduce cytokines. J Dermatol Sci 1998; 17: 223-232.
16. Victor FC, Gottlieb AB, Menter A. Changing paradigms in dermatology: tumor necrosis factor-alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis. Clin Dermatol 2003; 21: 392-397.
17. Schottelius AJ, Moldawer LL, Dinarello CA, et al. Biology of tumor necrosis factor-alpha - implications for psoriasis. Exp Dermatol 2004; 13: 193-222.
18. Baran W, Szepietowski JC, Mazur G, Baran E. A -308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris No difference either between psoriasis type I and type II patients. Acta Dermatovenerol Alp Panonica Adriat 2006; 15: 113-118.
19. Kim TG, Pyo CW, Hur SS, et al. Polymorphisms of tumor necrosis factor (TNF) alpha and beta genes in Korean patients with psoriasis. Arch Dermatol Res 2003; 295: 8-13.
20. Tsunemi Y, Nishibu A, Saeki H, et al. Lack of association between the promoter polymorphisms at positions -308 and -238 of the tumor necrosis factor alpha gene and psoriasis vulgaris in Japanese patients. Dermatology 2003; 207: 371-374.
21. Nishibu A, Oyama N, Nakamura K, Kaneko F. Lack of association of TNF-238A and -308A in Japanese patients with psoriasis vulgaris, psoriatic arthritis and generalized pustular psoriasis. J Dermatol Sci 2002; 29: 181-184.
22. Höhler T, Kruger A, Schneider PM, et al. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997; 109: 562-565.
23. Soell M, Lett E, Holveck F, et al. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan-binding protein inhibits TNF-alpha release. J Immunol 1995; 154: 851-860.
24. Chaka W, Verheul AF, Vaishnav VV, et al. Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose-binding protein. J Immunol 1997; 159: 2979-2985.
25. Ghezzi MC, Raponi G, Angeletti S, Mancini C. Serum-mediated enhancement of TNF-alpha release by human monocytes stimulated with the yeast form of Candida albicans. J Infect Dis 1998; 178: 1743-1749.
26. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532-540.
27. Epstein J, Eichbaum Q, Sheriff S, Ezekowitz RA. The collectins in innate immunity. Curr Opin Immunol 1996; 8: 29-35.
28. Jacobsen S, Madsen HO, Klarlund M, et al. The influence of mannose-binding lectin polymorphisms on disease outcome in early polyarthritis. J Rheumatol 2001; 28: 935-942.
29. Werth VP, Berlin JA, Callen JP, et al. Mannose-binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermatomyositis. J Invest Dermatol 2002; 119: 1394-1399.
30. Barkokebas A, de Albuquerque T, Carvalho A, et al. Mannose-binding lectin gene (MBL-2) polymorphism in oral lichen planus. Clin Oral Investig 2011; 15: 699-704.